GRI-2

N/A

Report date: 2023/06/14 09:12:19

Base Information

Drug NameGRI-2

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionGlycine reuptake inhibitors

TargetsGlycine transporters (GlyTs)

Therapy Area/IndicationsSpinal Cord Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNps Allelix Corp

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNps Allelix Corp

Active IndicationsN/A

Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A

Related LinksN/A